Clinical Trials Logo

Vaginitis clinical trials

View clinical trials related to Vaginitis.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT04984460 Enrolling by invitation - Vaginitis Clinical Trials

Morphological Detection of Liquid-based Thin-layer Film-making Fungi for Fungal Vaginitis in Multiple Hospitals

Start date: July 9, 2021
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to compare the results of different detection methods for non-gestational fungal vaginitis (VVC), and to evaluate the significance of different fungal states in the results for diagnosis and treatment.

NCT ID: NCT04045379 Enrolling by invitation - Clinical trials for Postmenopausal Symptoms

LASER and Radiofrequency and Genitourinary Syndrome of Menopause

EPMLARF-arm1
Start date: August 5, 2019
Phase: N/A
Study type: Interventional

This is a randomized controlled trial to evaluate the use of LASER, Micro Ablative radiofrequency and topic strogen to treat symptoms of vulvovaginal atrophy of post menopause.

NCT ID: NCT02558179 Enrolling by invitation - Clinical trials for Vaginosis, Bacterial

Diagnosing Bacterial Vaginosis/Vaginitis (BV) Using the Gynecologene Test Method

SAGE
Start date: September 2015
Phase: N/A
Study type: Observational [Patient Registry]

This study is designed as a prospective evaluation of the diagnostic performance of the multiplex nucleic acid-based genetic test (Gynecologene Next-Generation Sequencing test) to identify known significant causative organisms in bacterial vaginosis/vaginitis and other major pathogens and normal commensals in symptomatic women during the reproductive years. Vaginal fluid samples will be split and tested with the comparator methods and Nugent score, with the results evaluated according to sensitivity, specificity, positive predictive value, and negative predictive value. Laboratorians performing each test will be blinded to the clinical history and any prior test results to minimize ascertainment bias. Each subject will be followed routinely for up to 6 weeks after initial visit for vaginosis/vaginitis by telephone or office visit at the discretion of the treating physician.